It also regulates one-carbon metabolism and epigenetic modification of histones, and increased SERBP1 expression in cancers such as leukemia, ovarian, prostate, liver, and glioblastoma is correlated with poor patient outcomes [67]. This evidence concerns the gene SERBP1 and leukemia.